Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 16, 2015 - Issue 15
Submit an article Journal homepage
1,030
Views
15
CrossRef citations to date
0
Altmetric
Review

The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus

Kashif M MunirUniversity of Maryland School of Medicine, Center for Diabetes and Endocrinology, Division of Endocrinology, Diabetes, and Nutrition, 827 Linden Ave, 2nd Floor, Baltimore, MD 21201, USA
, MD (Assistant Professor) &
Stephen N DavisUniversity of Maryland School of Medicine, Department of Medicine, 22 South Greene Street, Baltimore, MD 21201, USA+1 41 03 28 24 88; +1 41 03 28 86 88; [email protected]
, MBBS FRCP FACP (Theodore E. Woodward Professor of Medicine, Professor of Physiology Chairman)
Pages 2331-2341 | Published online: 01 Sep 2015

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kashif M. Munir & Stephen N. Davis. (2023) How close are we to personalized pharmacotherapies and innovative technology for type 1 diabetes management?. Expert Opinion on Pharmacotherapy 24:15, pages 1661-1663.
Read now
Yoon Kook Kim, Kashif M. Munir & Stephen N. Davis. (2023) Type 1 diabetes: key drug targets and how they could influence future therapeutics. Expert Opinion on Therapeutic Targets 27:1, pages 31-40.
Read now

Articles from other publishers (13)

Subir Kumar Juin, Sathnur Pushpakumar, Suresh C. Tyagi & Utpal Sen. (2022) Glucosidase inhibitor, Nimbidiol ameliorates renal fibrosis and dysfunction in type-1 diabetes. Scientific Reports 12:1.
Crossref
Xiaoling Cai, Chu Lin, Wenjia Yang, Lin Nie & Linong Ji. (2021) Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes & Metabolism Journal 45:3, pages 312-325.
Crossref
Hailan Zou, Lili Liu, Jia Guo, Hongjuan Wang, Siyun Liu, Yixuan Xing, Chao Deng, Yang Xiao & Zhiguang Zhou. (2020) Sodium–glucose cotransporter inhibitors as add‐on therapy in addition to insulin for type 1 diabetes mellitus: A meta‐analysis of randomized controlled trials. Journal of Diabetes Investigation 12:4, pages 546-556.
Crossref
Torben Biester, Olga Kordonouri & Thomas Danne. (2019) Beyond type 2 diabetes: sodium glucose co‐transporter‐inhibition in type 1 diabetes. Diabetes, Obesity and Metabolism 21:S2, pages 53-61.
Crossref
Agata Chobot, Katarzyna Górowska-Kowolik, Magdalena Sokołowska & Przemysława Jarosz-Chobot. (2018) Obesity and diabetes-Not only a simple link between two epidemics. Diabetes/Metabolism Research and Reviews 34:7, pages e3042.
Crossref
Gagan Priya & Sanjay Kalra. (2017) A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?. Diabetes Therapy 9:1, pages 349-361.
Crossref
Qixian Wang, Min Long, Hua Qu, Rufei Shen, Rui Zhang, Jing Xu, Xin Xiong, Hui Wang & Hongting Zheng. (2018) DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Journal of Diabetes Research 2018, pages 1-10.
Crossref
Cristen P. Page, Brian Fitzgerald & Emily M. Hawes. (2017) Latent autoimmune diabetes of adulthood: case report. Clinical Diabetes and Endocrinology 3:1.
Crossref
Michael Valitsky, Amnon Hoffman, Terry Unterman & Jacob Bar-Tana. (2017) Insulin sensitizer prevents and ameliorates experimental type 1 diabetes. American Journal of Physiology-Endocrinology and Metabolism 313:6, pages E672-E680.
Crossref
Caio Yogi Yonamine, Erika Pinheiro-Machado, Maria Luiza Michalani, Helayne Soares Freitas, Maristela Mitiko Okamoto, Maria Lucia Corrêa-Giannella & Ubiratan Fabres Machado. (2016) Resveratrol improves glycemic control in insulin-treated diabetic rats: participation of the hepatic territory. Nutrition & Metabolism 13:1.
Crossref
Morgan Comee & Anne Peters. (2016) The changing therapeutic armamentarium for patients with type 1 diabetes. Current Opinion in Endocrinology, Diabetes & Obesity 23:2, pages 106-110.
Crossref
Simona Cernea & Avivit Cahn. (2016) Diabetes mellitus: in search of an improved classification and treatment algorithm. Revista Romana de Medicina de Laborator 24:1, pages 9-20.
Crossref
Stanley S. Schwartz, Solomon Epstein, Barbara E. Corkey, Struan F.A. Grant, James R. GavinIIIIII & Richard B. Aguilar. (2016) The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema. Diabetes Care 39:2, pages 179-186.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.